Lungpacer wins the Jon DeHaan Foundation Innovation in Cardiology Award

“On behalf of myself and the Lungpacer medical team we would like to express our deep appreciation for being selected as the winner of the Jon DeHaan Foundation’s Award for Innovation in Cardiology at the 2021 TCT Conference. This recognition will further support the development of Lungpacer’s transvascular neurostimulation therapy, which is designed to empower natural independent breathing and improve the quality of life for people dependent on artificial ventilation. The Jon DeHaan Foundation has a rich history of providing crucial support for early-stage transformative medical therapies such as ours. In that spirit, we are pleased to pay forward the financial component of this award to the second-place team at AquaPass to multiply the impact of this prestigious recognition and further foster medical innovation.” ​ ~ Doug Evans President & CEO